Use of S-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders

Details for Australian Patent Application No. 2004212328 (hide)

Owner Novartis AG

Inventors Cryan, John F.; Vassout, Annick; Schmutz, Markus; Bilbe, Graeme; Mcallister, Kevin Hall; Gentsch, Conrad

Agent Davies Collison Cave

Pub. Number AU-B-2004212328

PCT Pub. Number WO2004/071152

Priority 0303614.2 17.02.03 GB; 0303613.4 17.02.03 GB; 0307281.6 28.03.03 GB; 0307278.2 28.03.03 GB

Filing date 16 February 2004

Wipo publication date 26 August 2004

Acceptance publication date 17 January 2008

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/071152 Priority application(s): WO2004/071152

17 January 2008 Application Accepted

  Published as AU-B-2004212328

15 May 2008 Standard Patent Sealed

8 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212335-Piperazine-2-carboxamide derivatives

2004212327-Use of R-10-hydroxy-10, 11-dihydro-carbamazepine in neuropathic pain